The DOI matches its Crossref record; 1,217 of the 1,217 references it cites were found in a registry or an index.
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Open accessAbstract
Despite considerable progress in genome- and proteome-based high-throughput screening methods and in rational drug design, the increase in approved drugs in the past decade did not match the increase of drug development costs. Network description and analysis not only gives a systems-level understanding of drug action and disease complexity, but can also help to improve the efficiency of drug design. We give a comprehensive assessment of the analytical tools of network topology and dynamics. The state-of-the-art use of chemical similarity, protein structure, protein-protein interaction, signaling, genetic interaction and metabolic networks in the discovery of drug targets is summarized. We propose that network targeting follows two basic strategies. The “central hit strategy” selectively targets central node/edges of the flexible networks of infectious agents or cancer cells to kill them. The “network influence strategy” works against other diseases, where an efficient reconfiguration of rigid networks needs to be achieved. It is shown how network techniques can help in the identification of single-target, edgetic, multi-target and allo-network drug target candidates. We review the recent boom in network methods helping hit identification, lead selection optimizing drug efficacy, as well as minimizing side-effects and drug toxicity. Successful network-based drug development strategies are shown through the examples of infections, cancer, metabolic diseases, neurodegenerative diseases and aging. Summarizing >1200 references we suggest an optimized protocol of network-aided drug development, and provide a list of systems-level hallmarks of drug quality. Finally, we highlight network-related drug development trends helping to achieve these hallmarks by a cohesive, global approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 1,217
Topological structure analysis of the protein-protein interaction network in budding yeast
Bu, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg340 · Cited by 747
Klipp, E., Wierling, C., & Liebermeister, W. (1994) · Cited by 744
Systematic Discovery of In Vivo Phosphorylation Networks
Linding, R., Jensen, L. J., Ostheimer, G. J., van Vugt, M. A. T. M., Jørgensen, C., Miron, I. M., Diella, F., Colwill, K., Taylor, L., Elder, K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.052 · Cited by 735
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., Nadal, C., Gomis, R. R., Manova-Todorova, K., & Massagué, J. (2007) · Nature · doi:10.1038/nature05760 · Cited by 727
Protein flexibility predictions using graph theory
Jacobs, D. J., Rader, A. J., Kuhn, L. A., & Thorpe, M. F. (2001) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.1081 · Cited by 727
Activity driven modeling of time varying networks
Perra, N., Gonçalves, B., Pastor-Satorras, R., & Vespignani, A. (2012) · Scientific Reports · doi:10.1038/srep00469 · Cited by 709 · cited 1×
“A number of recent publications explored the effect of time-window changes on the structure of social networks (Krings et al., 2012; Perra et al., 2012).”
BackgroundGlobal organization of metabolic fluxes in the bacterium Escherichia coli
Almaas, E., Kovács, B., Vicsek, T., Oltvai, Z. N., & Barabási, A.-L. (2004) · Nature · doi:10.1038/nature02289 · Cited by 709
Protein Sectors: Evolutionary Units of Three-Dimensional Structure
Halabi, N., Rivoire, O., Leibler, S., & Ranganathan, R. (2009) · Cell · doi:10.1016/j.cell.2009.07.038 · Cited by 707
Dynamic modularity in protein interaction networks predicts breast cancer outcome
Taylor, I. W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q., & Wrana, J. L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1522 · Cited by 697
Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology
Karp, P. D., Paley, S. M., Krummenacker, M., Latendresse, M., Dale, J. M., Lee, T. J., Kaipa, P., Gilham, F., Spaulding, A., Popescu, L., et al. (2010) · Briefings in Bioinformatics · doi:10.1093/bib/bbp043 · Cited by 694
A human functional protein interaction network and its application to cancer data analysis
Wu, G., Feng, X., & Stein, L. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-r53 · Cited by 692
Secreted microRNAs: a new form of intercellular communication
Chen, X., Liang, H., Zhang, J., Zen, K., & Zhang, C.-Y. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.12.001 · Cited by 690
AKUTSU, T., MIYANO, S., & KUHARA, S. (1998) · Biocomputing '99 · doi:10.1142/9789814447300_0003 · Cited by 689
Lee, M. J., Ye, A. S., Gardino, A. K., Heijink, A. M., Sorger, P. K., MacBeath, G., & Yaffe, M. B. (2012) · Cell · doi:10.1016/j.cell.2012.03.031 · Cited by 680
Similarity index based on local paths for link prediction of complex networks
Lü, L., Jin, C.-H., & Zhou, T. (2009) · Physical Review E · doi:10.1103/physreve.80.046122 · Cited by 678
On the Method of Theoretical Physics
Einstein, A. (1934) · Philosophy of Science · doi:10.1086/286316 · Cited by 675
Mutual exclusivity analysis identifies oncogenic network modules
Ciriello, G., Cerami, E., Sander, C., & Schultz, N. (2012) · Genome Research · doi:10.1101/gr.125567.111 · Cited by 675
A Dynamic Network Approach for the Study of Human Phenotypes
Hidalgo, C. A., Blumm, N., Barabási, A.-L., & Christakis, N. A. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000353 · Cited by 674
Allosteric regulation and catalysis emerge via a common route
Goodey, N. M., & Benkovic, S. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.98 · Cited by 667
Reverse engineering gene networks using singular value decomposition and robust regression
Yeung, M. K. S., Tegnér, J., & Collins, J. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092576199 · Cited by 667
Network‐based global inference of human disease genes
Wu, X., Jiang, R., Zhang, M. Q., & Li, S. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.27 · Cited by 660
Folding funnels, binding funnels, and protein function
Tsai, C., Kumar, S., Ma, B., & Nussinov, R. (1999) · Protein Science · doi:10.1110/ps.8.6.1181 · Cited by 648
Self-citationSuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647 · cited 1×
“bank.ca Knox et al., 2011 PharmGKB http://pharmgkb.org Thorn et al., 2010 Therapeutic Target Database http://bidd.nus.edu.sg/group/cjttd/ TTD_HOME.asp Zhu et al., 2012b MATADOR http://matador.embl.de Günther et al., 2008 Supertarget http://insilico.charite.de/supertarget Hecker et al., 2012 KEGG DRUG http://genome.jp/…”
BackgroundAn abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people
Nelson, M. R., Wegmann, D., Ehm, M. G., Kessner, D., St. Jean, P., Verzilli, C., Shen, J., Tang, Z., Bacanu, S.-A., Fraser, D., et al. (2012) · Science · doi:10.1126/science.1217876 · Cited by 647
The impact of natural products upon modern drug discovery
Ganesan, A. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.016 · Cited by 646
Protein–Protein Interactions Essentials: Key Concepts to Building and Analyzing Interactome Networks
De Las Rivas, J., & Fontanillo, C. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000807 · Cited by 644
Drug target validation and identification of secondary drug target effects using DNA microarrays
Marton, M. J., DeRisi, J. L., Bennett, H. A., Iyer, V. R., Meyer, M. R., Roberts, C. J., Stoughton, R., Burchard, J., Slade, D., Dai, H., et al. (1998) · Nature Medicine · doi:10.1038/3282 · Cited by 643
Network-based prediction of human tissue-specific metabolism
Shlomi, T., Cabili, M. N., Herrgård, M. J., Palsson, B. Ø., & Ruppin, E. (2008) · Nature Biotechnology · doi:10.1038/nbt.1487 · Cited by 637
Mapping Change in Large Networks
Rosvall, M., & Bergstrom, C. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008694 · Cited by 630
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Generic Indicators for Loss of Resilience Before a Tipping Point Leading to Population Collapse
Dai, L., Vorselen, D., Korolev, K. S., & Gore, J. (2012) · Science · doi:10.1126/science.1219805 · Cited by 626
Visualization of omics data for systems biology
Gehlenborg, N., O'Donoghue, S. I., Baliga, N. S., Goesmann, A., Hibbs, M. A., Kitano, H., Kohlbacher, O., Neuweger, H., Schneider, R., Tenenbaum, D., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1436 · Cited by 620
Systematic discovery of multicomponent therapeutics
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337088100 · Cited by 620 · cited 5×
“Experimental testing of drug-drug interactions may be used to infer the underlying molecular network structure, and as drug-drug interaction networks (Borisy et al., 2003; Yeh et al., 2006; Lehár et al., 2007; Jia et al., 2009) may be used to predict additional drug-drug interactions using network modularization metho…”
BackgroundInfluentialNetwork modeling links breast cancer susceptibility and centrosome dysfunction
Pujana, M. A., Han, J.-D. J., Starita, L. M., Stevens, K. N., Tewari, M., Ahn, J. S., Rennert, G., Moreno, V., Kirchhoff, T., Gold, B., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.2 · Cited by 618
Molecular similarity: a key technique in molecular informatics
Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 614
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Dudley, J. T., Sirota, M., Shenoy, M., Pai, R. K., Roedder, S., Chiang, A. P., Morgan, A. A., Sarwal, M. M., Pasricha, P. J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002648 · Cited by 605
Caspi, R., Altman, T., Dreher, K., Fulcher, C. A., Subhraveti, P., Keseler, I. M., Kothari, A., Krummenacker, M., Latendresse, M., Mueller, L. A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1014 · Cited by 601
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., Milo, R., Cohen-Saidon, C., Liron, Y., Kam, Z., et al. (2008) · Science · doi:10.1126/science.1160165 · Cited by 596
The regulation of autophagy – unanswered questions
Chen, Y., & Klionsky, D. J. (2011) · Journal of Cell Science · doi:10.1242/jcs.064576 · Cited by 591
Herrgård, M. J., Swainston, N., Dobson, P., Dunn, W. B., Arga, K. Y., Arvas, M., Blüthgen, N., Borger, S., Costenoble, R., Heinemann, M., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1492 · Cited by 588
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sharma, S. V., Haber, D. A., & Settleman, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2820 · Cited by 586
JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles
Portales-Casamar, E., Thongjuea, S., Kwon, A. T., Arenillas, D., Zhao, X., Valen, E., Yusuf, D., Lenhard, B., Wasserman, W. W., & Sandelin, A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp950 · Cited by 577
Predicting disease genes using protein–protein interactions
Oti, M., Snel, B., Huynen, M. A., & Brunner, H. G. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041376 · Cited by 574
Backstrom, L., Boldi, P., Rosa, M., Ugander, J., & Vigna, S. (2012) · Proceedings of the 4th Annual ACM Web Science Conference · doi:10.1145/2380718.2380723 · Cited by 567
D'Angelo, M. A., Raices, M., Panowski, S. H., & Hetzer, M. W. (2009) · Cell · doi:10.1016/j.cell.2008.11.037 · Cited by 565
Annotation Transfer Between Genomes: Protein–Protein Interologs and Protein–DNA Regulogs
Yu, H., Luscombe, N. M., Lu, H. X., Zhu, X., Xia, Y., Han, J.-D. J., Bertin, N., Chung, S., Vidal, M., & Gerstein, M. (2004) · Genome Research · doi:10.1101/gr.1774904 · Cited by 563
Subnets of scale-free networks are not scale-free: Sampling properties of networks
Stumpf, M. P. H., Wiuf, C., & May, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501179102 · Cited by 561
Modeling cellular machinery through biological network comparison
Sharan, R., & Ideker, T. (2006) · Nature Biotechnology · doi:10.1038/nbt1196 · Cited by 559
Huang, S., Ernberg, I., & Kauffman, S. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.07.003 · Cited by 556
Getting connected: analysis and principles of biological networks
Zhu, X., Gerstein, M., & Snyder, M. (2007) · Genes & Development · doi:10.1101/gad.1528707 · Cited by 554
Random Boolean network models and the yeast transcriptional network
Kauffman, S., Peterson, C., Samuelsson, B., & Troein, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036429100 · Cited by 553
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Information Transduction Capacity of Noisy Biochemical Signaling Networks
Cheong, R., Rhee, A., Wang, C. J., Nemenman, I., & Levchenko, A. (2011) · Science · doi:10.1126/science.1204553 · Cited by 547
Idiotypic Networks and Other Preconceived Ideas
Jerne, N. K., & Cocteau, J. (1984) · Immunological Reviews · doi:10.1111/j.1600-065x.1984.tb00484.x · Cited by 542
TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support
Vergoulis, T., Vlachos, I. S., Alexiou, P., Georgakilas, G., Maragkakis, M., Reczko, M., Gerangelos, S., Koziris, N., Dalamagas, T., & Hatzigeorgiou, A. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1161 · Cited by 541
Efficient sampling algorithm for estimating subgraph concentrations and detecting network motifs
Kashtan, N., Itzkovitz, S., Milo, R., & Alon, U. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth163 · Cited by 537
Feedback control of intercellular signalling in development
Freeman, M. (2000) · Nature · doi:10.1038/35042500 · Cited by 535
GeneNetWeaver: in silico benchmark generation and performance profiling of network inference methods
Schaffter, T., Marbach, D., & Floreano, D. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr373 · Cited by 535
Drug–target interaction prediction by random walk on the heterogeneous network
Chen, X., Liu, M.-X., & Yan, G.-Y. (2012) · Molecular BioSystems · doi:10.1039/c2mb00002d · Cited by 533
Reconstruction of cellular signalling networks and analysis of their properties
Papin, J. A., Hunter, T., Palsson, B. O., & Subramaniam, S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1570 · Cited by 532
GraphScope: parameter-free mining of large time-evolving graphs
Sun, J., Faloutsos, C., Papadimitriou, S., & Yu, P. S. (2007) · Proceedings of the 13th ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/1281192.1281266 · Cited by 532
Keskin, O., Ma, B., & Nussinov, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.077 · Cited by 519
Self-citationComputational prediction of human metabolic pathways from the complete human genome
Romero, P., Wagg, J., Green, M. L., Kaiser, D., Krummenacker, M., & Karp, P. D. (2004) · Genome Biology · doi:10.1186/gb-2004-6-1-r2 · Cited by 517
Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast
Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C.-H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.040 · Cited by 515
Ma, H., & Zeng, A.-P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.270 · Cited by 514
Global and Local Architecture of the Mammalian microRNA–Transcription Factor Regulatory Network
Shalgi, R., Lieber, D., Oren, M., & Pilpel, Y. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030131 · Cited by 512
Network analyses in systems pharmacology
Berger, S. I., & Iyengar, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp465 · Cited by 510
NetPath: a public resource of curated signal transduction pathways
Kandasamy, K., Mohan, S. S., Raju, R., Keerthikumar, S., Kumar, G. S. S., Venugopal, A. K., Telikicherla, D., Navarro, J. D., Mathivanan, S., Pecquet, C., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-1-r3 · Cited by 505
Topological analysis and interactive visualization of biological networks and protein structures
Doncheva, N. T., Assenov, Y., Domingues, F. S., & Albrecht, M. (2012) · Nature Protocols · doi:10.1038/nprot.2012.004 · Cited by 503
Integrative analysis of the cancer transcriptome
Rhodes, D. R., & Chinnaiyan, A. M. (2005) · Nature Genetics · doi:10.1038/ng1570 · Cited by 498
Global topological features of cancer proteins in the human interactome
Jonsson, P. F., & Bates, P. A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl390 · Cited by 496
The implications of human metabolic network topology for disease comorbidity
Lee, D.-S., Park, J., Kay, K. A., Christakis, N. A., Oltvai, Z. N., & Barabási, A.-L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802208105 · Cited by 495
LEDA: A platform for combinatorial and geometric computing
(2000) · Computers & Mathematics with Applications · doi:10.1016/s0898-1221(00)90217-7 · Cited by 489
A robustness-based approach to systems-oriented drug design
Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
Using process diagrams for the graphical representation of biological networks
Kitano, H., Funahashi, A., Matsuoka, Y., & Oda, K. (2005) · Nature Biotechnology · doi:10.1038/nbt1111 · Cited by 483 · cited 1×
“…Longabaugh, 2012 BisoGenet http://bio.cigb.edu.cu/bisogenet-cytoscape Martin et al., 2010 CellDesigner http://www.celldesigner.org Kitano et al., 2005 Cell Illustrator http://www.cellillustrator.com Nagasaki et al., 2011 CFinder http://www.cfinder.org Adamcsek et al., 2006…”
BackgroundTherapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
Zhu, F., Shi, Z., Qin, C., Tao, L., Liu, X., Xu, F., Zhang, L., Song, Y., Liu, X., Zhang, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr797 · Cited by 480
Franke, L., Bakel, H. V., Fokkens, L., de Jong, E. D., Egmont-Petersen, M., & Wijmenga, C. (2006) · The American Journal of Human Genetics · doi:10.1086/504300 · Cited by 476
Predicting selective drug targets in cancer through metabolic networks
Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.35 · Cited by 476
Stability of graph communities across time scales
Delvenne, J.-C., Yaliraki, S. N., & Barahona, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903215107 · Cited by 475
Inferring Domain–Domain Interactions From Protein–Protein Interactions
Deng, M., Mehta, S., Sun, F., & Chen, T. (2002) · Genome Research · doi:10.1101/gr.153002 · Cited by 474
Relating Three-Dimensional Structures to Protein Networks Provides Evolutionary Insights
Kim, P. M., Lu, L. J., Xia, Y., & Gerstein, M. B. (2006) · Science · doi:10.1126/science.1136174 · Cited by 472
Osprey: a network visualization system
Breitkreutz, B.-J., Stark, C., & Tyers, M. (2003) · Genome Biology · doi:10.1186/gb-2003-4-3-r22 · Cited by 471
Yamanishi, Y., Kotera, M., Kanehisa, M., & Goto, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq176 · Cited by 470
Can we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Circuitry and Dynamics of Human Transcription Factor Regulatory Networks
Neph, S., Stergachis, A. B., Reynolds, A., Sandstrom, R., Borenstein, E., & Stamatoyannopoulos, J. A. (2012) · Cell · doi:10.1016/j.cell.2012.04.040 · Cited by 467 · cited 1×
“The human transcription factor regulatory network has a basic architecture, which is independent from the cell type and is complemented by cell type specific segments (Bhardwaj et al., 2010; Gerstein et al., 2012; Neph et al., 2012).”
BackgroundMolecular similarity analysis in virtual screening: foundations, limitations and novel approaches
Eckert, H., & Bajorath, J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.011 · Cited by 466
Discovering disease-genes by topological features in human protein–protein interaction network
Xu, J., & Li, Y. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl467 · Cited by 461
Tomlinson, I. P. M., Novelli, M. R., & Bodmer, W. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14800 · Cited by 458
HINT: High-quality protein interactomes and their applications in understanding human disease
Das, J., & Yu, H. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-92 · Cited by 458
Cancer as a robust system: implications for anticancer therapy
Kitano, H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1300 · Cited by 456
Membranes: A meeting point for lipids, proteins and therapies
Escribá, P. V., González‐Ros, J. M., Goñi, F. M., Kinnunen, P. K. J., Vigh, L., Sánchez‐Magraner, L., Fernández, A. M., Busquets, X., Horváth, I., & Barceló‐Coblijn, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00281.x · Cited by 454
Network visualization and analysis of gene expression data using BioLayout Express3D
Theocharidis, A., van Dongen, S., Enright, A. J., & Freeman, T. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.177 · Cited by 454
Bhattacharyya, R. P., Reményi, A., Yeh, B. J., & Lim, W. A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142710 · Cited by 454
Goehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., Droege, A., Lindenberg, K. S., Knoblich, M., Haenig, C., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.016 · Cited by 453
Prediction of protein–protein interactions by docking methods
Smith, G. R., & Sternberg, M. J. E. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00285-3 · Cited by 446
Linear Motif Atlas for Phosphorylation-Dependent Signaling
Miller, M. L., Jensen, L. J., Diella, F., Jørgensen, C., Tinti, M., Li, L., Hsiung, M., Parker, S. A., Bordeaux, J., Sicheritz-Ponten, T., et al. (2008) · Science Signaling · doi:10.1126/scisignal.1159433 · Cited by 442
A Network Representation of Protein Structures: Implications for Protein Stability
Brinda, K. V., & Vishveshwara, S. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.064485 · Cited by 442
Gandhi, T. K. B., Zhong, J., Mathivanan, S., Karthick, L., Chandrika, K. N., Mohan, S. S., Sharma, S., Pinkert, S., Nagaraju, S., Periaswamy, B., et al. (2006) · Nature Genetics · doi:10.1038/ng1747 · Cited by 442
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Systematic interpretation of genetic interactions using protein networks
Kelley, R., & Ideker, T. (2005) · Nature Biotechnology · doi:10.1038/nbt1096 · Cited by 437
The Edinburgh human metabolic network reconstruction and its functional analysis
Ma, H., Sorokin, A., Mazein, A., Selkov, A., Selkov, E., Demin, O., & Goryanin, I. (2007) · Molecular Systems Biology · doi:10.1038/msb4100177 · Cited by 435 · cited 2×
“…that metabolic network data are often still incomplete, and often reflect optimal growth conditions (Edwards & Palsson, 2000a; Forster et al., 2003; Duarte et al., 2007; Ma et al., 2007; Shlomi et al., 2008, 2009; Folger et al., 2011; Holme, 2011; Chavali et al., 2012; Szalay-Bekő et al., 2012).”
BackgroundPathguide: a Pathway Resource List
Bader, G. D. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj126 · Cited by 435 · cited 3×
“A list of several other pathway databases can be found at PathGuide (http://pathguide.org; Bader et al., 2006).”
BackgroundMethodInfluentialHuntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration
Kaltenbach, L. S., Romero, E., Becklin, R. R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030082 · Cited by 434
Reverse engineering gene networks: integrating genetic perturbations with dynamical modeling
Tegnér, J., Yeung, M. K. S., Hasty, J., & Collins, J. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0933416100 · Cited by 433
The spatial architecture of protein function and adaptation
McLaughlin Jr, R. N., Poelwijk, F. J., Raman, A., Gosal, W. S., & Ranganathan, R. (2012) · Nature · doi:10.1038/nature11500 · Cited by 433
Controlling edge dynamics in complex networks
Nepusz, T., & Vicsek, T. (2012) · Nature Physics · doi:10.1038/nphys2327 · Cited by 430
Classes of complex networks defined by role-to-role connectivity profiles
Guimerà, R., Sales-Pardo, M., & Amaral, L. A. N. (2007) · Nature Physics · doi:10.1038/nphys489 · Cited by 425
Recurrence based time series analysis by means of complex network methods
DONNER, R. V., SMALL, M., DONGES, J. F., MARWAN, N., ZOU, Y., XIANG, R., & KURTHS, J. (2011) · International Journal of Bifurcation and Chaos · doi:10.1142/s0218127411029021 · Cited by 423
Yu, H., Chen, J., Xu, X., Li, Y., Zhao, H., Fang, Y., Li, X., Zhou, W., Wang, W., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037608 · Cited by 423
Untangling the wires: A strategy to trace functional interactions in signaling and gene networks
Kholodenko, B. N., Kiyatkin, A., Bruggeman, F. J., Sontag, E., Westerhoff, H. V., & Hoek, J. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192442699 · Cited by 422
Fuzzy communities and the concept of bridgeness in complex networks
Nepusz, T., Petróczi, A., Négyessy, L., & Bazsó, F. (2008) · Physical Review E · doi:10.1103/physreve.77.016107 · Cited by 421
PathBLAST: a tool for alignment of protein interaction networks
Kelley, B. P., Yuan, B., Lewitter, F., Sharan, R., Stockwell, B. R., & Ideker, T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh411 · Cited by 420
Genome-wide inferring gene–phenotype relationship by walking on the heterogeneous network
Li, Y., & Patra, J. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq108 · Cited by 418
Are splicing mutations the most frequent cause of hereditary disease?
López-Bigas, N., Audit, B., Ouzounis, C., Parra, G., & Guigó, R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.047 · Cited by 412
Edwards, A. M., Isserlin, R., Bader, G. D., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · Nature · doi:10.1038/470163a · Cited by 411
The modular nature of genetic diseases
Oti, M., & Brunner, H. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00708.x · Cited by 410
BRENDA, the enzyme information system in 2011
Scheer, M., Grote, A., Chang, A., Schomburg, I., Munaretto, C., Rother, M., Sohngen, C., Stelzer, M., Thiele, J., & Schomburg, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1089 · Cited by 409
Protein clefts in molecular recognition and function.
Laskowski, R. A., Luscombe, N. M., Swindells, M. B., & Thornton, J. M. (1996) · PubMed · doi:10.1002/pro.5560051206 · Cited by 407
Herpesviral Protein Networks and Their Interaction with the Human Proteome
Uetz, P., Dong, Y.-A., Zeretzke, C., Atzler, C., Baiker, A., Berger, B., Rajagopala, S. V., Roupelieva, M., Rose, D., Fossum, E., et al. (2006) · Science · doi:10.1126/science.1116804 · Cited by 407
Wachi, S., Yoneda, K., & Wu, R. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti688 · Cited by 406
TransmiR: a transcription factor–microRNA regulation database
Wang, J., Lu, M., Qiu, C., & Cui, Q. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp803 · Cited by 404
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
Use of genome-wide association studies for drug repositioning
Sanseau, P., Agarwal, P., Barnes, M. R., Pastinen, T., Richards, J. B., Cardon, L. R., & Mooser, V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2151 · Cited by 397
IsoRankN: spectral methods for global alignment of multiple protein networks
Liao, C.-S., Lu, K., Baym, M., Singh, R., & Berger, B. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp203 · Cited by 396
Rosvall, M., & Bergstrom, C. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018209 · Cited by 393
Signaling Network Model of Chromatin
Schreiber, S. L., & Bernstein, B. E. (2002) · Cell · doi:10.1016/s0092-8674(02)01196-0 · Cited by 393
NetworKIN: a resource for exploring cellular phosphorylation networks
Linding, R., Jensen, L. J., Pasculescu, A., Olhovsky, M., Colwill, K., Bork, P., Yaffe, M. B., & Pawson, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm902 · Cited by 393
Robustness can evolve gradually in complex regulatory gene networks with varying topology
Ciliberti, S., Martin, O. C., & Wagner, A. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030015 · Cited by 390 · cited 2×
“…bridging positions) driving disease-specific network traffic are preferred targets of the network influence strategy (Kitano, 2004a, 2004b, 2007; Ciliberti et al., 2007; Antal et al., 2009; Hase et al., 2009; Zanzoni et al., 2009; Fliri et al., 2010; Cornelius et al., 2011; Farkas et al., 2011;…”
BackgroundEpstein–Barr virus and virus human protein interaction maps
Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702332104 · Cited by 388 · cited 3×
“…host–pathogen networks proved to be very efficient in complex targeting strategies in the case of viral/host interactomes (Uetz et al., 2006; Calderwood et al., 2007; de Chassey et al., 2008; Chautard et al., 2009; Navratil et al., 2009, 2011; Brown et al., 2011; Prussia et al., 2011; Xu…”
BackgroundThree-dimensional reconstruction of protein networks provides insight into human genetic disease
Wang, X., Wei, X., Thijssen, B., Das, J., Lipkin, S. M., & Yu, H. (2012) · Nature Biotechnology · doi:10.1038/nbt.2106 · Cited by 385
Hepatitis C virus infection protein network
de Chassey, B., Navratil, V, Tafforeau, L., Hiet, M. S., Aublin‐Gex, A., Agaugué, S., Meiffren, G., Pradezynski, F., Faria, B. F., Chantier, T., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.66 · Cited by 384
Drug–target interaction prediction by learning from local information and neighbors
Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X.-L., & Zheng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 382
Cancer: A Systems Biology disease
Hornberg, J. J., Bruggeman, F. J., Westerhoff, H. V., & Lankelma, J. (2006) · Biosystems · doi:10.1016/j.biosystems.2005.05.014 · Cited by 381 · cited 6×
“Many targets of anti-cancer therapies are not directly cancer-related (Hornberg et al., 2006; Cheng et al., 2012c).”
BackgroundInfluentialHeat shock proteins as emerging therapeutic targets
Sõti, C., Nagy, E., Giricz, Z., Vígh, L., Csermely, P., & Ferdinandy, P. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706396 · Cited by 380
Self-citationThe cognitive paradigm and the immunological homunculus
Cohen, I. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90024-2 · Cited by 380
Li, S., Zhang, B., & Zhang, N. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s10 · Cited by 380
Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins
Rozenblatt-Rosen, O., Deo, R. C., Padi, M., Adelmant, G., Calderwood, M. A., Rolland, T., Grace, M., Dricot, A., Askenazi, M., Tavares, M., et al. (2012) · Nature · doi:10.1038/nature11288 · Cited by 378
SMPDB: The Small Molecule Pathway Database
Frolkis, A., Knox, C., Lim, E., Jewison, T., Law, V., Hau, D. D., Liu, P., Gautam, B., Ly, S., Guo, A. C., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1002 · Cited by 375
Anti- and pro-tumor functions of autophagy
Morselli, E., Galluzzi, L., Kepp, O., Vicencio, J.-M., Criollo, A., Maiuri, M. C., & Kroemer, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.006 · Cited by 375
Herzog, F., Kahraman, A., Boehringer, D., Mak, R., Bracher, A., Walzthoeni, T., Leitner, A., Beck, M., Hartl, F.-U., Ban, N., et al. (2012) · Science · doi:10.1126/science.1221483 · Cited by 371
Strategies for optimizing combinations of molecularly targeted anticancer agents
Dancey, J. E., & Chen, H. X. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2089 · Cited by 365
Disease candidate gene identification and prioritization using protein interaction networks
Chen, J., Aronow, B. J., & Jegga, A. G. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-73 · Cited by 364
Edgetic perturbation models of human inherited disorders
Zhong, Q., Simonis, N., Li, Q., Charloteaux, B., Heuze, F., Klitgord, N., Tam, S., Yu, H., Venkatesan, K., Mou, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.80 · Cited by 359
Rao, F., & Caflisch, A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.063 · Cited by 358
The power of protein interaction networks for associating genes with diseases
Navlakha, S., & Kingsford, C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq076 · Cited by 358
Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
Zhao, S., & Iyengar, R. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134520 · Cited by 358
iMAT: an integrative metabolic analysis tool
Zur, H., Ruppin, E., & Shlomi, T. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq602 · Cited by 357
Hot Spots for Allosteric Regulation on Protein Surfaces
Reynolds, K. A., McLaughlin, R. N., & Ranganathan, R. (2011) · Cell · doi:10.1016/j.cell.2011.10.049 · Cited by 356
Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence
Rotem, E., Loinger, A., Ronin, I., Levin-Reisman, I., Gabay, C., Shoresh, N., Biham, O., & Balaban, N. Q. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004333107 · Cited by 355
Masaki, T. (2002) · Ecological Studies · doi:10.1007/978-4-431-67879-3_6 · Cited by 353
Conservation and Rewiring of Functional Modules Revealed by an Epistasis Map in Fission Yeast
Roguev, A., Bandyopadhyay, S., Zofall, M., Zhang, K., Fischer, T., Collins, S. R., Qu, H., Shales, M., Park, H.-O., Hayles, J., et al. (2008) · Science · doi:10.1126/science.1162609 · Cited by 352
Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast
Papp, B., Pál, C., & Hurst, L. D. (2004) · Nature · doi:10.1038/nature02636 · Cited by 352
Functional classification of drugs by properties of their pairwise interactions
Yeh, P., Tschumi, A. I., & Kishony, R. (2006) · Nature Genetics · doi:10.1038/ng1755 · Cited by 350
PINA v2.0: mining interactome modules
Cowley, M. J., Pinese, M., Kassahn, K. S., Waddell, N., Pearson, J. V., Grimmond, S. M., Biankin, A. V., Hautaniemi, S., & Wu, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr967 · Cited by 350
Reprogramming of miRNA networks in cancer and leukemia
Volinia, S., Galasso, M., Costinean, S., Tagliavini, L., Gamberoni, G., Drusco, A., Marchesini, J., Mascellani, N., Sana, M. E., Abu Jarour, R., et al. (2010) · Genome Research · doi:10.1101/gr.098046.109 · Cited by 349
Unveiling the role of network and systems biology in drug discovery
Pujol, A., Mosca, R., Farrés, J., & Aloy, P. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.006 · Cited by 346
Effect of sampling on topology predictions of protein-protein interaction networks
Han, J.-D. J., Dupuy, D., Bertin, N., Cusick, M. E., & Vidal, M. (2005) · Nature Biotechnology · doi:10.1038/nbt1116 · Cited by 344
Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks
di Bernardo, D., Thompson, M. J., Gardner, T. S., Chobot, S. E., Eastwood, E. L., Wojtovich, A. P., Elliott, S. J., Schaus, S. E., & Collins, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1075 · Cited by 344
Kovács, I. A., Palotai, R., Szalay, M. S., & Csermely, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012528 · Cited by 338
Self-citationRobust Salmonella metabolism limits possibilities for new antimicrobials
Becker, D., Selbach, M., Rollenhagen, C., Ballmaier, M., Meyer, T. F., Mann, M., & Bumann, D. (2006) · Nature · doi:10.1038/nature04616 · Cited by 335
Residues crucial for maintaining short paths in network communication mediate signaling in proteins
del Sol, A., Fujihashi, H., Amoros, D., & Nussinov, R. (2006) · Molecular Systems Biology · doi:10.1038/msb4100063 · Cited by 331
Self-citationBisoGenet: a new tool for gene network building, visualization and analysis
Martin, A., Ochagavia, M. E., Rabasa, L. C., Miranda, J., Fernandez-de-Cossio, J., & Bringas, R. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-91 · Cited by 329
Small-World Communication of Residues and Significance for Protein Dynamics
Atilgan, A. R., Akan, P., & Baysal, C. (2004) · Biophysical Journal · doi:10.1016/s0006-3495(04)74086-2 · Cited by 327
Kirkpatrick, P., & Ellis, C. (2004) · Nature · doi:10.1038/432823a · Cited by 327
Genomic analysis of essentiality within protein networks
Yu, H., Greenbaum, D., Xin Lu, H., Zhu, X., & Gerstein, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.04.008 · Cited by 325
Suthram, S., Dudley, J. T., Chiang, A. P., Chen, R., Hastie, T. J., & Butte, A. J. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000662 · Cited by 322
Integrated network analysis platform for protein-protein interactions
Wu, J., Vallenius, T., Ovaska, K., Westermarck, J., Mäkelä, T. P., & Hautaniemi, S. (2009) · Nature Methods · doi:10.1038/nmeth.1282 · Cited by 320
Control Centrality and Hierarchical Structure in Complex Networks
Liu, Y.-Y., Slotine, J.-J., & Barabási, A.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044459 · Cited by 320
Blank, L. M., Kuepfer, L., & Sauer, U. (2005) · Genome Biology · doi:10.1186/gb-2005-6-6-r49 · Cited by 317
Autophagy and metastasis: another double-edged sword
Kenific, C. M., Thorburn, A., & Debnath, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.10.008 · Cited by 311
Human Disease-Drug Network Based on Genomic Expression Profiles
Hu, G., & Agarwal, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006536 · Cited by 310
Principles of microRNA regulation of a human cellular signaling network
Cui, Q., Yu, Z., Purisima, E. O., & Wang, E. (2006) · Molecular Systems Biology · doi:10.1038/msb4100089 · Cited by 309
Genomic-scale prioritization of drug targets: the TDR Targets database
Agüero, F., Al-Lazikani, B., Aslett, M., Berriman, M., Buckner, F. S., Campbell, R. K., Carmona, S., Carruthers, I. M., Chan, A. W. E., Chen, F., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2684 · Cited by 306
Bodenmiller, B., Wanka, S., Kraft, C., Urban, J., Campbell, D., Pedrioli, P. G., Gerrits, B., Picotti, P., Lam, H., Vitek, O., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2001182 · Cited by 306
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Rocha, G. Z., Dias, M. M., Ropelle, E. R., Osório-Costa, F., Rossato, F. A., Vercesi, A. E., Saad, M. J. A., & Carvalheira, J. B. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2243 · Cited by 305
Autophagy as a therapeutic target in cancer
Chen, N., & Karantza, V. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.14622 · Cited by 303
Recent Advances on the Role of Topological Indices in Drug Discovery Research
Estrada, E., & Uriarte, E. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371923 · Cited by 303
Some New Trends in Chemical Graph Theory
García-Domenech, R., Gálvez, J., de Julián-Ortiz, J. V., & Pogliani, L. (2008) · Chemical Reviews · doi:10.1021/cr0780006 · Cited by 302
Discovering the first microRNA-targeted drug
Lindow, M., & Kauppinen, S. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208082 · Cited by 302
Small-world behavior in time-varying graphs
Tang, J., Scellato, S., Musolesi, M., Mascolo, C., & Latora, V. (2010) · Physical Review E · doi:10.1103/physreve.81.055101 · Cited by 301
Boolean network simulations for life scientists
Albert, I., Thakar, J., Li, S., Zhang, R., & Albert, R. (2008) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-3-16 · Cited by 301
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300
Probing genetic overlap among complex human phenotypes
Rzhetsky, A., Wajngurt, D., Park, N., & Zheng, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704820104 · Cited by 298
Systems biology, metabolic modelling and metabolomics in drug discovery and development
Kell, D. B. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.004 · Cited by 297
Gene perturbation and intervention in probabilistic Boolean networks
Shmulevich, I., Dougherty, E. R., & Zhang, W. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.10.1319 · Cited by 296
An overview of the PubChem BioAssay resource
Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B. A., Suzek, T. O., Wang, J., Xiao, J., Zhang, J., & Bryant, S. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp965 · Cited by 295
Network properties of genes harboring inherited disease mutations
Feldman, I., Rzhetsky, A., & Vitkup, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701722105 · Cited by 295
Systematic Mapping of Genetic Interaction Networks
Dixon, S. J., Costanzo, M., Baryshnikova, A., Andrews, B., & Boone, C. (2009) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.073003.114751 · Cited by 295
Bender, A., Jenkins, J. L., Scheiber, J., Sukuru, S. C. K., Glick, M., & Davies, J. W. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800249s · Cited by 294
Lage, K., Hansen, N. T., Karlberg, E. O., Eklund, A. C., Roque, F. S., Donahoe, P. K., Szallasi, Z., Jensen, T. S., & Brunak, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810772105 · Cited by 292
Systematic discovery of nonobvious human disease models through orthologous phenotypes
McGary, K. L., Park, T. J., Woods, J. O., Cha, H. J., Wallingford, J. B., & Marcotte, E. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910200107 · Cited by 292
iPath2.0: interactive pathway explorer
Yamada, T., Letunic, I., Okuda, S., Kanehisa, M., & Bork, P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr313 · Cited by 292
A network view of disease and compound screening
Schadt, E. E., Friend, S. H., & Shaywitz, D. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2826 · Cited by 291
GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data
Rzhetsky, A., Iossifov, I., Koike, T., Krauthammer, M., Kra, P., Morris, M., Yu, H., Duboué, P. A., Weng, W., Wilbur, W. J., et al. (2004) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2003.10.001 · Cited by 291
Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features
He, Z., Zhang, J., Shi, X.-H., Hu, L.-L., Kong, X., Cai, Y.-D., & Chou, K.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009603 · Cited by 288
PDTD: a web-accessible protein database for drug target identification
Gao, Z., Li, H., Zhang, H., Liu, X., Kang, L., Luo, X., Zhu, W., Chen, K., Wang, X., & Jiang, H. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-104 · Cited by 288
A systems approach to prion disease
Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.10 · Cited by 287
Recovering time-varying networks of dependencies in social and biological studies
Ahmed, A. A., & Xing, E. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901910106 · Cited by 287
Uncovering Network Systems Within Protein Structures
Greene, L. H., & Higman, V. A. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.061 · Cited by 287
Cited by
Vital nodes identification in complex networks
Lü, L., Chen, D., Ren, X.-L., Zhang, Q.-M., Zhang, Y.-C., & Zhou, T. (2016) · Physics Reports · doi:10.1016/j.physrep.2016.06.007 · Cited by 1,183
The H-index of a network node and its relation to degree and coreness
Lü, L., Zhou, T., Zhang, Q.-M., & Stanley, H. E. (2016) · Nature Communications · doi:10.1038/ncomms10168 · Cited by 690
Network propagation: a universal amplifier of genetic associations
Cowen, L., Ideker, T., Raphael, B. J., & Sharan, R. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.38 · Cited by 657
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
Preuer, K., Lewis, R. P. I., Hochreiter, S., Bender, A., Bulusu, K. C., & Klambauer, G. (2018) · Bioinformatics · doi:10.1093/bioinformatics/btx806 · Cited by 653
Lipinski, C. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.029 · Cited by 609
Metadata
- Authors
- Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 138
- Issue
- 3
- Pages
- 333-408
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2140239055
- Cited by
- 892
- References
- 1,217
- FWCI
- 107.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.